Innovent Presents Updated Data From Innovative Anti-CLDN18.2 ADC (IBI343) Phase 1 Study in Patients with Advanced Pancreatic Cancer at the ESMO Asia Congress 2024
SAN FRANCISCO and SUZHOU, China, Dec. 8, 2024 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metaboli
SYM Investors Have Opportunity to Lead Symbotic Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
NEW YORK, Dec. 8, 2024 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Symbotic Inc. (NASDAQ: SYM) between February 8, 2024 and November 26, 2024, both dates inclusive (the “Class Per
Media Advisory – Deputy Prime Minister’s itinerary for Monday, December 9, 2024
OTTAWA, ON, Dec. 8, 2024 /CNW/ – Note: All times local. Ottawa, Ontario Private meetings. 3:30 p.m. The Deputy Prime Minister will appear before the House of Commons Standing Committee on Industry and Technology. She will be joined by the Minister of Innovation, Science and Industry, Franço
Media Advisory – Prime Minister’s itinerary for Monday, December 9, 2024
OTTAWA, ON, Dec. 8, 2024 /CNW/ – Halifax Regional Municipality, Nova Scotia The Prime Minister will meet with the Premier of Nova Scotia, Tim Houston. He will be joined by the Minister of Housing, Infrastructure and Communities, Sean Fraser. Note for media: Pooled photo opportunity at the begi
AEHR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Aehr Test Systems, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, Dec. 8, 2024 /PRNewswire/ — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Aehr Test Systems, Inc. (“Aehr” or “the Company”) (NASDAQ:
AbbVie Announces Emotional Impact Report on Mental Health of Underrepresented CLL Cancer Patients
-New insights show Black, Hispanic, and Asian patients have more negative emotional experiences and outlooks with their chronic lymphocytic leukemia (CLL) diagnosis and treatment journeys–CLL is one of the most common leukemias among adults affecting more than 200,000 people in the U.S.1,2 NO
SK Life Science, Inc. Presents XCOPRI® (cenobamate tablets) CV Data at the AES 2024 Annual Meeting Showing a Deeper Understanding of Cenobamate’s Dual Mechanism of Action
PARAMUS, N.J., Dec. 8, 2024 /PRNewswire/ — SK Life Science, Inc., a global leader in treatments for central nervous system (CNS) disorders and a subsidiary of SK Biopharmaceuticals Co., Ltd., presented data at the American Epilepsy Society (AES) Annual Meeting, showcasing its antiseizure medic
Canada Border Services Agency reports three escapes at Laval Immigration Holding Centre
MONTREAL, Dec. 8, 2024 /CNW/ – Three Chilean nationals, Bryan Ulises Moya Rojas, Diego Nicolas Flores Sepulveda and Daniel Eliseo Gonzalez Ihrig escaped last night from the Laval Immigration Holding Centre at 300 Montée Saint-François in Laval, Quebec. Arrest warrants have been issued and t
WTCH 24 – Countless historical results and a new superpower emerged
BUDAPEST, Hungary, Dec. 8, 2024 /PRNewswire/ — Every World Teqball Championships is unique in some way, and the 2024 edition was no different. The last one was the most colorful with a record number of participating countries, and this year, we had the most athletes signing up for the event,
TECVAYLI® (teclistamab-cqyv) demonstrates potential as frontline combination therapy for patients with newly diagnosed multiple myeloma
100 percent of evaluable patients for minimal residual disease (MRD) testing achieved MRD negativity in MajesTEC-5 as induction therapy and MajesTEC-4 as maintenance therapy SAN DIEGO, Dec. 8, 2024 /PRNewswire/ — Johnson & Johnson (NYSE:JNJ) today announced new frontline data featuring TEC
